Vaxcyte Inc (PCVX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $60.00
• Market Cap: $9.15B
• EPS: $-4.85
• 52-Week High: $76.61
• 52-Week Low: $27.66

Market Sentiment

Vaxcyte Inc currently has a Bullish sentiment score of 0.24.

About Vaxcyte Inc

Vaxcyte, Inc. (PCVX) is a cutting-edge biotechnology firm based in Foster City, California, dedicated to pioneering next-generation vaccines to address global infectious diseases. Utilizing its proprietary technology platform, Vaxcyte is developing innovative vaccine candidates that aim to deliver strong immunity and fulfill critical unmet medical needs. With a robust pipeline driven by a strong emphasis on research and development, the company is strategically positioned to significantly adv...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Vaxcyte Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PCVX pay dividends?

Vaxcyte Inc (PCVX) does not currently pay a regular dividend.

What is PCVX's market cap?

Vaxcyte Inc (PCVX) has a market capitalization of $9.15B with a current stock price of $60.00.